Shared Decision-Making: A Successful Framework for Starting Buprenorphine

Saturday, April 26, 2025

4:15 PM – 5:30 PM

Presenter(s)

Wesley Brewington, CPC, CDC II, NCPRSS

Recovery Support Specialist
Boulder
Anchorage, Alaska
Drew Mossman, FNP, PMHNP

Nurse Practitioner
Boulder Care
Portland, Oregon
Danielle Bellosi, NCPRSS, CPRC

Peer Supervisor
Boulder Care
Boise, Idaho
Elizabeth B. Ryan, MD, FASAM

Medical Director
Boulder Care
Portland, Oregon

Non-presenting author(s)

Stephen Alexander Martin, MD, EdM

Medical Director for Research, Education, and Quality
Boulder Care
Northfield, Massachusetts

The advent of illicitly-manufactured fentanyl (IMF) has destabilized previous standard opioid transitions to buprenorphine. The vast majority of people affected are in the outpatient setting where we have the least data. This Focus Session will introduce attendees to an effective, established shared decision-making process where patients select the transition method that works best for them.

Learning Objectives:

Learners will be able to:

Describe the challenges of outpatient transitions from fentanyl to buprenorphine
Identify elements of shared decision-making and informed choice that better support patients in this transition.
Compare and contrast shared decision-making approaches for patients with various needs and preferences.

Disclosure(s):

Wesley Brewington, CPC, CDC II, NCPRSS: No financial relationships to disclose

Drew Mossman, FNP, PMHNP: No financial relationships to disclose

Danielle Bellosi, NCPRSS, CPRC: No financial relationships to disclose

Elizabeth B. Ryan, MD, FASAM: No financial relationships to disclose

Stephen Alexander Martin, MD, EdM: No financial relationships to disclose